Chongqing Xi'an Pharmaceutical Co., Ltd., a well-known brand of Yinhua lotion and women's lotion, a famous trademark in Chongqing, is a high-tech enterprise integrating R&D, production and sales of Chinese herbal medicine planting/Chinese medicine decoction piece processing
Xi'an Pharmaceutical Co., Ltd. originated from "Wushu Fangcaotang" in 1698 A.D., inheriting the pharmaceutical essence of "Chongqing General Factory of Traditional Chinese Medicine", and has a history of more than 300 years. The company has always adhered to the corporate philosophy of "Debu World, Medicine for the People", adhered to the corporate goal of "creating a first-class enterprise and building a century-old goodwill", and has now developed into a comprehensive pharmaceutical enterprise integrating R&D, production and sales, and has been rated as a national key high-tech enterprise, a national leading enterprise in the biological industry base, and a national key leading enterprise in agricultural industrialization.
Xi'an Pharmaceutical Co., Ltd. is located in Hechuan Industrial Park, Chongqing, with total assets of 1.25 billion yuan, covering an area of 330 acres, with a total construction area of 76,207 m2 and a total investment of 600 million yuan, and 15 dosage forms such as granules, capsules and tablets have passed the 2010 GMP certification, with an annual output value of 5 billion yuan. The new production base realizes the standardization of the plant, the automation of the production process, and the scientific protection of the environment.
The company has abundant product resources and has 166 production approvals, of which 71 varieties are listed in the "National Basic Medical Insurance Drug Catalog"; 22 varieties were included in the National Essential Medicines List; 12 protected varieties of traditional Chinese medicine, 2 high-quality and high-price varieties.
The company has two major commercial organizations: Xi'an Pharmaceutical Sales Company; Xi'an Kangze Pharmaceutical Chain Co., Ltd.; Four major marketing agencies: prescription drug marketing center, OTC marketing center, general drug marketing center, new medical marketing center; The implementation of the "wide coverage, deep cultivation" marketing strategy, the sales network covers 31 provinces, autonomous regions, municipalities directly under the central government and Southeast Asia, Europe, the Americas and other overseas markets, the formation of the provincial capital city general hospital to the district and county and township health centers, individual clinics, retail pharmacies deep cultivation of the sales pattern, is committed to building orthopedics, pediatrics, oncology, dermatology and other competitive product lines, to achieve the annual sales growth of more than 50% of the target.
The company has two R&D institutions: Chongqing Cisco Pharmaceutical Research Institute Co., Ltd., focusing on the development of chemical drugs, traditional Chinese medicine and natural medicines, and health products; Chongqing Kerun Biomedical R&D Co., Ltd., focusing on the research and development of biologics; It has a number of municipal-level technological innovation platforms such as Chongqing Postdoctoral Research Station, Chongqing Enterprise Technology Center, and Chongqing Traditional Chinese Medicine Preparation Process Engineering Technology Research Center. The company has always taken "science and technology" as a means, adhered to the policy of "combining imitation and innovation, and paying equal attention to the research and development of drugs and health products", and formed a research and development pattern of "screening a batch, developing a batch, and reserving a batch".
In order to adapt to the country's continuous reform of the medical and health system and the new economic situation, the company vigorously implements talent strategy, brand strategy and innovation strategy; Inherit the essence of Wu Shufang's traditional Chinese medicine culture for 300 years, and build a corporate culture system with "Debu world, medicine for the common people" as the core; Build the two core competitiveness of market access and marketing, achieve subversive development, and strive to build Xi'an into a 10-billion-level pharmaceutical enterprise in the next 6~8 years.
